167 related articles for article (PubMed ID: 23881300)
1. Computed diffusion-weighted imaging using 3-T magnetic resonance imaging for prostate cancer diagnosis.
Ueno Y; Takahashi S; Kitajima K; Kimura T; Aoki I; Kawakami F; Miyake H; Ohno Y; Sugimura K
Eur Radiol; 2013 Dec; 23(12):3509-16. PubMed ID: 23881300
[TBL] [Abstract][Full Text] [Related]
2. Computed diffusion-weighted MRI for prostate cancer detection: the influence of the combinations of b-values.
Ueno Y; Takahashi S; Ohno Y; Kitajima K; Yui M; Kassai Y; Kawakami F; Miyake H; Sugimura K
Br J Radiol; 2015 Apr; 88(1048):20140738. PubMed ID: 25605347
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
[TBL] [Abstract][Full Text] [Related]
4. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging.
Kitajima K; Kaji Y; Fukabori Y; Yoshida K; Suganuma N; Sugimura K
J Magn Reson Imaging; 2010 Mar; 31(3):625-31. PubMed ID: 20187206
[TBL] [Abstract][Full Text] [Related]
6. Detectability of low and intermediate or high risk prostate cancer with combined T2-weighted and diffusion-weighted MRI.
Doo KW; Sung DJ; Park BJ; Kim MJ; Cho SB; Oh YW; Ko YH; Yang KS
Eur Radiol; 2012 Aug; 22(8):1812-9. PubMed ID: 22466514
[TBL] [Abstract][Full Text] [Related]
7. The value of diffusion-weighted MRI for prostate cancer detection and localization.
Yağci AB; Ozari N; Aybek Z; Düzcan E
Diagn Interv Radiol; 2011 Jun; 17(2):130-4. PubMed ID: 20694948
[TBL] [Abstract][Full Text] [Related]
8. Ultra-high b-value diffusion-weighted MRI for the detection of prostate cancer with 3-T MRI.
Ueno Y; Kitajima K; Sugimura K; Kawakami F; Miyake H; Obara M; Takahashi S
J Magn Reson Imaging; 2013 Jul; 38(1):154-60. PubMed ID: 23292979
[TBL] [Abstract][Full Text] [Related]
9. The clinical value of diffusion-weighted imaging in combination with T2-weighted imaging in diagnosing prostate carcinoma: a systematic review and meta-analysis.
Wu LM; Xu JR; Ye YQ; Lu Q; Hu JN
AJR Am J Roentgenol; 2012 Jul; 199(1):103-10. PubMed ID: 22733900
[TBL] [Abstract][Full Text] [Related]
10. Diffusion-weighted MR imaging for the evaluation of seminal vesicle invasion in prostate cancer: initial results.
Kim CK; Choi D; Park BK; Kwon GY; Lim HK
J Magn Reson Imaging; 2008 Oct; 28(4):963-9. PubMed ID: 18821631
[TBL] [Abstract][Full Text] [Related]
11. [Clinical value of diffusion-weighted magnetic resonance imaging for localization of prostate cancer--comparison with the step sections of radical prostatectomy].
Hatano K; Tsuda K; Kawamura N; Kakuta Y; Takada T; Adachi S; Hara T; Yamaguchi S
Nihon Hinyokika Gakkai Zasshi; 2010 May; 101(4):603-8. PubMed ID: 20535988
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of ultra-high-b-value 3.0-T diffusion-weighted MR imaging for detection of prostate cancer.
Ohgiya Y; Suyama J; Seino N; Hashizume T; Kawahara M; Sai S; Saiki M; Munechika J; Hirose M; Gokan T
Clin Imaging; 2012; 36(5):526-31. PubMed ID: 22920357
[TBL] [Abstract][Full Text] [Related]
13. Predicting Prostate Biopsy Outcomes: A Preliminary Investigation on Screening with Ultrahigh B-Value Diffusion-Weighted Imaging as an Innovative Diagnostic Biomarker.
Zhang K; Shen Y; Zhang X; Ma L; Wang H; An N; Guo A; Ye H
PLoS One; 2016; 11(3):e0151176. PubMed ID: 26963936
[TBL] [Abstract][Full Text] [Related]
14. Quantitative evaluation of computed and voxelwise computed diffusion-weighted imaging in breast cancer.
Cheng Q; Ye S; Fu C; Zhou J; He X; Miao H; Xu N; Wang M
Br J Radiol; 2019 Aug; 92(1100):20180978. PubMed ID: 31291125
[TBL] [Abstract][Full Text] [Related]
15. Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI.
Kim CK; Park BK; Lee HM
J Magn Reson Imaging; 2009 Feb; 29(2):391-7. PubMed ID: 19161194
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer detection with MRI: is dynamic contrast-enhanced imaging necessary in addition to diffusion-weighted imaging?
Iwazawa J; Mitani T; Sassa S; Ohue S
Diagn Interv Radiol; 2011 Sep; 17(3):243-8. PubMed ID: 20859852
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the prostate imaging reporting and data system for the detection of prostate cancer by the results of targeted biopsy of the prostate.
Baur AD; Maxeiner A; Franiel T; Kilic E; Huppertz A; Schwenke C; Hamm B; Durmus T
Invest Radiol; 2014 Jun; 49(6):411-20. PubMed ID: 24598440
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer: utility of fusion of T2-weighted and high b-value diffusion-weighted images for peripheral zone tumor detection and localization.
Rosenkrantz AB; Mannelli L; Kong X; Niver BE; Berkman DS; Babb JS; Melamed J; Taneja SS
J Magn Reson Imaging; 2011 Jul; 34(1):95-100. PubMed ID: 21698707
[TBL] [Abstract][Full Text] [Related]
19. Whole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequences.
Larbi A; Omoumi P; Pasoglou V; Michoux N; Triqueneaux P; Tombal B; Cyteval C; Lecouvet FE
Eur Radiol; 2019 Aug; 29(8):4503-4513. PubMed ID: 30413957
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and Diagnostic Performance of Voxelwise Computed Diffusion-Weighted Imaging in Breast Cancer.
Zhou J; Chen E; Xu H; Ye Q; Li J; Ye S; Cheng Q; Zhao L; Su MY; Wang M
J Magn Reson Imaging; 2019 Jun; 49(6):1610-1616. PubMed ID: 30328211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]